IPA Immunoprecise Antibodies Ltd 1715925 |
Balance Sheet |
Current Assets
|
12,502,000 |
Assets
|
59,963,000 |
Current Liabilities
|
12,409,000 |
Liabilities
|
27,286,000 |
Equity
|
32,677,000 |
Shares Out
|
26,945,000 |
Cash Flow Statement |
Operating Cash Flow
|
-4,067,000 |
Investing Cash Flow
|
-328,000 |
Market Analysis |
Market Cap
|
15,289,260 |
BVPS
|
1.21 |
PB
|
0.40 |
EPS
|
-0.78 |
PS
|
1.25 |
FCF
|
-4,395,000 |
|
Earnings |
Jul |
Aug |
Sep |
7/29 |
|
|
|
9/16 |
-0.15 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IPA documents filed with the SEC.
IPA Filings
Clear